Aromasin® Interventional Study Of Early Invasive Breast Cancer Patients In China

Clinical trial NCT01176916 · COMPLETED

Trial details

NCT number: NCT01176916
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Breast Neoplasms

Start date: 2011-02-09
Primary completion: 2018-11-30
Enrollment: 564

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.